Trump's US-Made Drug Decree Sows Uncertainty In Industry
A White House mandate forcing the federal government to buy critical drugs domestically offers flexibility for agencies, but its vague language creates uncertainty for businesses unsure of which drugs will be...To view the full article, register now.
Already a subscriber? Click here to view full article